R&D Pipelines
We have developed many differentiated products through various product planning, synthesis and formulation research for 15 years, and are currently generating sales from many customers in the commercial stage.
To view the table in detail, please scroll left and right..
No.
Research Code
Indication
Research
Synthesis
Formu-lation
Contract
Trial
BE or PE
PC
Phase1
Phase2
Phase3
Approval
01
KLT-0801
Opthalmic
02
KLT-0802
Opthalmic
03
KLT-1001
Anti-inflammatory
04
KLT-0801
Anti-inflammatory
05
KLT-0901
Opthalmic
06
KLT-1002
Anti-ulcerative
07
KLT-1101
Anti-coagulant
08
KLT-1504
Anti-diabetic
09
KLT-1401
Anti-fungal
10
KLT-1602
Anti-depressant
11
KLT-1301
Opthalmic
12
KLT-1302
Opthalmic
13
KLT-1506
Anti-diabetic
14
KLT-1507
Anti-diabetic
15
KLT-1604
Immuno-suppressant
16
KLT-1509
Anti-diabetic
17
KLT-1510
Anti-diabetic
18
KLT-1609
Opthalmic
19
KLT-1611
Anti-neoplastic
20
KLT-1514
Anti-diabetic
21
KLT-1515
Anti-diabetic
22
KLT-1404
Smoking Cessation